Benzylthiouracil
Chemical compound
- H03BA03 (WHO)
- 1-(1-cyclohexa-2,4-dienylmethyl)-7-thia-
3,5-diazabicyclo[4.1.0]hepta-3,5-dien-2-one
- 6336-50-1
Y
- 685814
- 597542 Y
- PZ35LUM333
- ChEMBL1491306
- DTXSID30873587
- Interactive image
- S=C1N/C(=C\C(=O)N1)Cc2ccccc2
InChI
- InChI=1S/C11H10N2OS/c14-10-7-9(12-11(15)13-10)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H2,12,13,14,15)Y
- Key:PNXBXCRWXNESOV-UHFFFAOYSA-NY
Benzylthiouracil (BTU) is an antithyroid preparation. It is a thioamide, closely related to propylthiouracil.
Adverse effects
Benzylthiouracil has been associated with severe adverse effects, notably vasculitis and subsequent ANCA-positive glomerulonephritis, as well as isolated reports of lung damage.[1][2][3][4]
References
- ^ Tieulie N, Huong DL, Andreu M, et al. (2002). "[ANCA associated glomerulonephritis related to benzylthiouracil]". Rev Méd Interne (in French). 23 (10): 853–6. doi:10.1016/S0248-8663(02)00694-X. PMID 12428489.
- ^ Kaaroud H, Khiari K, Ben Moussa F, Barbouch S, Boussema E, Ben Maïz H (2002). "[Vasculitis with renal and pulmonary involvement in a patient receiving benzylthiouracil for Graves disease]". Rev Méd Interne (in French). 23 (10): 857–61. doi:10.1016/S0248-8663(02)00704-X. PMID 12428490.
- ^ Braham A, Houman MH, Rais L, Ben Gborbel I, Lamloum M, Miled M (2004). "[Benzylthiouracil induced ANCA-positive vasculitis]". Presse Médicale (in French). 33 (19 Pt 1): 1331–3. doi:10.1016/S0755-4982(04)98919-1. PMID 15615240.
- ^ Thabet F, Sghiri R, Tabarki B, Ghedira I, Yacoub M, Essoussi AS (2006). "ANCA-associated diffuse alveolar hemorrhage due to benzylthiouracil". Eur J Pediatr. 165 (7): 435–6. doi:10.1007/s00431-005-0053-4. PMID 16622664.
- v
- t
- e
| Thyroid peroxidase inhibitors (thioamide) |
|
|---|---|
| Block conversion of T4 to T3 | |
| Sodium-iodide symporter inhibitor | |
| Other |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
